No association between fertility drugs and ovarian cancer, say University of Pittsburgh researchers

January 25, 2002

PITTSBURGH, Jan. 25 - Fertility drugs do not put women at a higher than average risk of ovarian cancer, according to the largest analysis to date on the topic, conducted by University of Pittsburgh Graduate School of Public Health (GSPH) researchers and published in the Feb. 1 issue of the American Journal of Epidemiology.

"For more than a decade, controversy has surrounded the relationships among infertility, fertility drug use and the risk of ovarian cancer," said Roberta Ness, M.D., M.P.H., associate professor of epidemiology at GSPH and principal investigator on the study. "This analysis helps put to rest the questions that have been troubling physicians and the women who endure arduous fertility treatments."

While no association was found between ovarian cancer and fertility drugs, the study does point out a link between ovarian cancer and certain specific causes of infertility -- namely, endometriosis and "unknown" reasons for infertility. The study suggests that some women who receive fertility treatments develop ovarian cancer because of underlying conditions that cause infertility, not because of the treatments themselves.

Investigators collected interview data on infertility and fertility drug use from eight case-control studies conducted between 1989 and 1999 in the United States, Denmark, Canada and Australia, including 5,207 women with ovarian cancer, and 7,705 women without ovarian cancer. In the study, infertility was signaled by prolonged unsuccessful episodes of trying to conceive, and by seeking medical help in conceiving.

Results showed that women who spent more than five years trying to conceive were at a 2.7-fold higher risk for ovarian cancer than those who tried for less than one year. Women who had used fertility drugs were not more likely to develop ovarian cancer than those who had never used fertility drugs. The risk of ovarian cancer dropped with each pregnancy.

Also, the infertile women who were most likely to develop ovarian cancer were those whose infertility resulted from endometriosis or from "unknown" causes.

Endometriosis is a condition in which cells from the uterine lining, or endometrium, migrate to various sites throughout the pelvis and attach to other organs, causing inflammation and pain, as well as infertility. In the newly published paper, Dr. Ness suggests that the local inflammation that is characteristic of endometriosis may play a role in ovarian cancer. Conversely, researchers are as yet unsure how to characterize "unknown" causes of infertility.

"We are actively working to better understand what are now unknown causes of infertility," said Dr. Ness. "Understanding this better will give us a window into the biology behind ovarian cancer and it will help to define the women in this high-risk group."

Researchers found that ovarian cancer was not associated with the following causes of infertility: ovulation or menstrual problems, ovarian cysts, blocked tubes, uterine development problems or cervical mucous and/or inflamed cervix.

Women who took fertility drugs but never became pregnant were more likely to have non-invasive tumors, according to the study, but the researchers suggest that more tumors were found among these women because they were under intense medical scrutiny while undergoing fertility treatment.
-end-
Additional Contact:
Frank Raczkiewicz
PHONE: (412) 624-2607
FAX: (412) 624-3184
E-MAIL: DudaK@msx.upmc.edu
RaczkiewiczFA@msx.upmc.edu

University of Pittsburgh Medical Center

Related Ovarian Cancer Articles from Brightsurf:

Ovarian cancer cells cooperate to metastasize
In a study on human ovarian cancer cells in mice, Harvard Medical School researchers discovered a transient, cooperative interaction between cell subpopulations that allows otherwise nonmetastatic tumor cells to become aggressive and spread.

Photodynamic therapy used to treat ovarian cancer
Photodynamic therapy (PDT) is one of the most promising methods of treating localized tumors.

Studying the development of ovarian cancer with organoids
Researchers from the group of Hans Clevers at the Hubrecht Institute have modeled the development and progression of high-grade serous ovarian cancer in mini-versions, or organoids, of the female reproductive organs of the mouse.

New class of drugs could treat ovarian cancer
A team of researchers across the University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.

How to catch ovarian cancer earlier
Ovarian cancer is often diagnosed too late for effective treatment.

New compound could help treat ovarian cancer
Scientists from the University of Sheffield have discovered a compound that could be more effective in treating certain cancers than standard chemotherapy.

Epigenetic markers of ovarian cancer
Insilico Medicine and its collaborators from Johns Hopkins and Insilico Medicine, used an integrated approach by coupling identification of genome-wide expression patterns in multiple cohorts of primary ovarian cancer samples and normal ovarian surface epithelium with innovative computational analysis of gene expression data, leading to the discovery of novel cancer-specific epigenetically silenced genes.

Ovarian cancer statistics, 2018
A new report from the American Cancer Society provides an overview of ovarian cancer occurrence and mortality data.

Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation
A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.

TGen-led study finds potent anti-cancer drug effect in rare ovarian cancer
An anti-cancer drug used to fight leukemia shows promise against a rare and aggressive type of ovarian cancer -- small cell carcinoma of the ovary hypercalcemic type (SCCOHT) -- which strikes young women and girls, according to a study led by the TGen.

Read More: Ovarian Cancer News and Ovarian Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.